[A case report of valproate encephalopathy].
A 24-years-old woman with epilepsy treated with valproic acid developed disorientation, acalculia, perseveration, slow responsiveness and loss of memory. The drug withdrawal induced a quick improvement of mental function. In this case, hyperammonemia, hypocarnitinemia, increased protein in cerebrospinal fluid were found. When the drug was discontinued, she had a dramatic improvement. Valproic acid caused encephalopathy because of metabolic abnormality in mitochondria in this case. In the cases of encephalopathy caused by valproic acid, the drug administration should be withdrawn, and appropriate measures had to be taken. In addition, elevation of ammonia in the blood, lactic acid and pyruic acid in the serum and cerebrospinal fluid, and decreased carnitine level in the serum will be useful to make a diagnosis of valproate-induced encephalopathy.
Miyamoto
T
T
Southern Tohoku Research Institute for Neuroscience, Fukushima.
Miyamoto
M
M
Hirata
K
K
Katayama
S
S
D000328:Adult; D000641:Ammonia / Q000097:blood; D000927:Anticonvulsants / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D001921:Brain / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis; D002331:Carnitine / Q000097:blood / Q000172:deficiency; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D015415:Biomarkers; D014635:Valproic Acid; D000641:Ammonia; D002331:Carnitine